Clinical trial

Dolutegravir in Pregnant HIV Mothers and Their Neonates

NCT03249181

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-01-22

PhasePHASE3

Study timeline

Study start (actual)2018-01-22Date precision: day

Registry last updated2025-02-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-1-infectionunresolved

Pregnancy Relatedunresolved

Interventions

DolutegravirDRUG · verified · RxNorm: dolutegravir

Standard of Care (EFV + 2 NRTI backbone)DRUG

Sponsors & collaborators

University of Liverpoollead sponsor

UNITAIDcollaborator

University of Cape Towncollaborator

Liverpool School of Tropical Medicinecollaborator

Infectious Diseases Institute, Ugandacollaborator

Radboud University Medical Centercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03249181 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.